Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Biofrontera (BFRI)
NASDAQ:BFRI
BFRI Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.65 - $2.43
Previous CloseN/A
Volume12.39M
Average Volume (3M)654.22K
Market Cap
$10.21M
Enterprise Value$5.79M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.39
Next Earnings
Apr 04, 2025EPS Estimate
-0.03Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.27
Shares Outstanding8,873,932
10 Day Avg. Volume107,761
30 Day Avg. Volume654,219
Standard Deviation0.27
R-Squared0.00283
Alpha-0.07
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.25
Price to Cash Flow (P/CF)-1.70
P/FCF Ratio0.00
Enterprise Value/Market Cap0.57
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit0.35
Enterprise Value/Ebitda-0.62
Forecast
1Y Price Target
$7.00Price Target Upside530.63% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
---
Biofrontera News
PremiumCompany Announcements
Biofrontera Secures $4.2M for Strategic Growth Initiatives
PremiumCompany Announcements
Biofrontera Inc. Reports Q3 2024 Earnings Growth
PremiumCompany Announcements
Biofrontera Announces Promising Phase 3 Study Results
---
BFRI FAQ
What was Biofrontera’s price range in the past 12 months?
Biofrontera lowest stock price was $0.65 and its highest was $2.43 in the past 12 months.
What is Biofrontera’s market cap?
Biofrontera’s market cap is $10.21M.
When is Biofrontera’s upcoming earnings report date?
Biofrontera’s upcoming earnings report date is Apr 04, 2025 which is in 40 days.
How were Biofrontera’s earnings last quarter?
Biofrontera released its earnings results on Nov 13, 2024. The company reported -$0.98 earnings per share for the quarter, missing the consensus estimate of -$0.835 by -$0.145.
Is Biofrontera overvalued?
According to Wall Street analysts Biofrontera’s price is currently Undervalued.
Does Biofrontera pay dividends?
Biofrontera does not currently pay dividends.
What is Biofrontera’s EPS estimate?
Biofrontera’s EPS estimate is -0.03.
How many shares outstanding does Biofrontera have?
Biofrontera has 8,873,932 shares outstanding.
What happened to Biofrontera’s price movement after its last earnings report?
Biofrontera reported an EPS of -$0.98 in its last earnings report, missing expectations of -$0.835. Following the earnings report the stock price went down -15.663%.
Which hedge fund is a major shareholder of Biofrontera?
Currently, no hedge funds are holding shares in BFRI
---
Company Description
Biofrontera
Biofrontera Inc is a biopharmaceutical company specializing in the commercialization of pharmaceutical products for the treatment of dermatological conditions, diseases caused by exposure to sunlight that result in sun damage to the skin. Its licensed products focus on the treatment of actinic keratoses, which are skin lesions that can sometimes lead to skin cancer. It also markets a topical antibiotic for the treatment of impetigo, a bacterial skin infection.
---
BFRI Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call reflected a balanced sentiment with notable achievements in revenue growth, cost reduction, and product approval, juxtaposed with challenges such as Hurricane Milton's impact, legal expenses, and ongoing losses.Read More>---
BFRI Stock 12 Month Forecast
Average Price Target
$7.00
▲(530.63% Upside)
Technical Analysis
Aclaris Therapeutics
―
Verona Pharma
―
Evolus
―
Arcutis Biotherapeutics
―
Journey Medical Corp
―
Best Analysts Covering BFRI
1 Year
1 Year Success Rate
2/12 ratings generated profit
1 Year Average Return
-54.70%
reiterated a buy rating 3 months ago
Copying Bruce Jackson's trades and holding each position for 1 Year would result in 16.67% of your transactions generating a profit, with an average return of -54.70% per trade.
---